Group or individual MDMA-assisted therapy for post-traumatic stress after October 2023 events
About this title
Read the official source — NCT07469098Understand this study
Who could participate?
This study is for people with PTSD. Listed age limits: 18 years to 75 years. Other eligibility criteria apply.
What will I do during this study?
The protocol includes: Completing questionnaires.
- Listed locations
- Beersheba and 1 more locationSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 168
- Sponsor
- Sheba Medical Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Israel
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT07469098
- Official title
Show the full official title
An Open-Label, Multicenter, Randomized, Non-Inferiority Study to Evaluate the Safety and Effectiveness of Group vs. Individual MDMA-Assisted Therapy in PTSD Patients Diagnosed Following the Events of October 7, 2023
Recruitment & locations
Beersheba · Pardesiyya
Interested in joining this study?
Questions about this study
What will I need to do?
You will complete questionnaires.
Who is behind this study?
The study sponsor is Sheba Medical Center, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including MDMA HCl.
Who can participate?
This study is for people with PTSD. Listed age limits: 18 years to 75 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
